Clinical Significance of Atrial Fibrillation Status in Patients With Percutaneous Coronary Intervention

Clinical Significance of Atrial Fibrillation Status in Patients With Percutaneous Coronary Intervention

Background: Patients undergoing percutaneous coronary intervention (PCI) often develop atrial fibrillation (AF). We investigated the clinical effects of AF status on in-hospital mortality and complications in patients with PCI using a recent large-scale nationwide dataset. Methods: Using a claims-ba...

Full description

Bibliographic Details
Main Authors:	Toka Hamaguchi, MD, Yoshitaka Iwanaga, MD, Michikazu Nakai, PhD, Yusuke Morita, MD, Moriaki Inoko, MD
Format:	Article
Language:	English
Published:	Elsevier 2021-11-01
Series:	CJC Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589790X21001839

Similar Items

Current status of atrial pacing algorithms for the prevention of atrial fibrillation: Should algorithms be used?
by: Toshiko Nakai, MD, et al.
Published: (2014-04-01)

The Association of Atrial Fibrillation Before Percutaneous Coronary Intervention With 1-Year Outcome in ST-Elevation Myocardial Infarction Patients
by: Eero Anttonen, MD, et al.
Published: (2021-10-01)

Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines Uptake
by: Marie-Claude Beaulieu, MD, et al.
Published: (2021-08-01)

Current overview of the genetic background of atrial fibrillation: Possible therapeutic gene targets for the treatment of atrial fibrillation
by: Tetsushi Furukawa, MD, PhD, et al.
Published: (2012-06-01)

Rescue percutaneous coronary intervention for sinus node dysfunction following left atrial flutter ablation
by: Yuichiro Miyazaki, MD, et al.
Published: (2021-08-01)

Coronary artery disease and atrial fibrillation
by: Georgios Ν. Theodorakis, MD FESC FACC
Published: (2017-05-01)

Successful interventional management of catastrophic coronary arterial air embolism during atrial fibrillation ablation
by: Khurram Ahmad, MD, et al.
Published: (2016-03-01)

Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention
by: Yunan Yu, et al.
Published: (2022-10-01)

Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: A. V. Panov
Published: (2021-09-01)

Inflammation and Atrial Fibrillation
by: Yasumi Endoh, MD PhD, et al.
Published: (2011-01-01)

Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality
by: Łukasz Pyka MD, PhD, et al.
Published: (2023-12-01)

Pharmacological Treatment for Atrial Fibrillation
by: Kaoru Sugi, MD PhD, et al.
Published: (2005-01-01)

Not Baseline Atrial Fibrillation but New-Onset Atrial Fibrillation and the Loss of Left Atrial Function Are Essential for Predicting Poor Outcomes in Non-ischemic Cardiomyopathy
by: Mana Okune, et al.
Published: (2021-12-01)

Left Atrial Tachycardia After Pulmonary Vein Isolation for Atrial Fibrillation
by: Kenichi Hashimoto, MD, et al.
Published: (2005-01-01)

Clinical implications of serum adiponectin on progression of atrial fibrillation
by: Naoko Yamaguchi, MD, PhD, et al.
Published: (2017-12-01)

Atrial Fibrillation and Atrial Fibrillation Intervals—Frequency Analysis and Interpretation—
by: Akihiko Shimizu, MD, PhD, FACC
Published: (2005-01-01)

Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Felice Gragnano, et al.
Published: (2023-12-01)

CLINICAL IMPRESSION: PLANNED PERCUTANEOUS CORONARY INTERVENTION IN A PATIENT WITH ATRIAL FIBRILLATION
by: Andrei I. Komarov
Published: (2018-12-01)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
by: Wenbin Lu, et al.
Published: (2021-10-01)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
by: Leonardo De Luca, et al.
Published: (2022-01-01)

Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
by: Monika Kozieł, et al.
Published: (2020-03-01)

Prognostic significance of Troponin I in patients undergoing primary percutaneous coronary intervention
by: Pratik Sudhir Sane, DNB, et al.
Published: (2021-11-01)

Characteristics of coronary artery disease among patients with atrial fibrillation compared to patients with sinus rhythm
by: Lukas J. Motloch, MD, PhD, et al.
Published: (2017-05-01)

Pulmonary vein isolation for paroxysmal atrial fibrillation in a patient with stand-alone unroofed coronary sinus
by: Masaki Tsuji, MD, et al.
Published: (2017-05-01)

Cryoballoon Ablation for Atrial Fibrillation
by: Jason G. Andrade, MD, et al.
Published: (2012-03-01)

Left atrial remodeling: Regional differences between paroxysmal and persistent atrial fibrillation
by: Rikitake Kogawa, MD, et al.
Published: (2017-10-01)

Identifying the Origin of Right and Left Ectopic Atrial Beats Triggering Atrial Fibrillation before Atrial Transseptal Procedure
by: Kimie Ohkubo, MD, et al.
Published: (2006-01-01)

Ablation on the mitral annulus for the treatment of atrial fibrillation: Anatomical consideration to prevent coronary injury
by: Hajime Imura, MD, et al.
Published: (2014-12-01)

Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
by: Yuji Murakawa, MD, et al.
Published: (2017-06-01)

Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post–Percutaneous Coronary Intervention
by: Caylie M. Poirier, PharmD, ACPR, et al.
Published: (2023-11-01)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
by: Yongqiang Fan, et al.
Published: (2022-02-01)

Thrombotic and hemorrhagic complications in atrial fibrillation patients, undergoing elective percutaneous coronary intervention
by: E N Krivosheeva, et al.
Published: (2019-09-01)

Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
by: Antonia Sambola, et al.
Published: (2016-01-01)

Transesophageal echocardiographic thromboembolic risk is associated with smoking status in patients with atrial fibrillation
by: Kyoko Inao, MD, et al.
Published: (2017-12-01)

Focal Pseudo-Atrial Fibrillation after Radiofrequency Ablation of Focal Atrial Tachycardia
by: Tadanobu Irie, MD, et al.
Published: (2010-01-01)

Irregular atrial flutter following pulmonary vein isolation for persistent atrial fibrillation
by: Tadanobu Irie, MD, et al.
Published: (2012-06-01)

Nationwide survey of catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF) – Report on antiarrhythmic drug therapy
by: Yuji Murakawa, MD, et al.
Published: (2014-10-01)

The usefulness of nifekalant for activation mapping of premature beat-triggered atrial fibrillation: Suppression of atrial fibrillation initiation without inhibiting premature beat
by: Masaharu Masuda, MD, et al.
Published: (2014-12-01)

Effect of Perindopril on Atrial Fibrillation Recurrence and Burden: Results of the Canadian Trial of Atrial Fibrillation (CTAF)-2
by: Lena Rivard, MD, MSc, et al.
Published: (2021-09-01)

Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada
by: Theresa E. Eberhardt, PharmD, ACPR, et al.
Published: (2022-04-01)